# Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of Care

> **NCT05366842** · PHASE2 · TERMINATED · sponsor: **Johns Hopkins University** · enrollment: 3 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Stravix lyopreserved placental tissue (LPT)
- **PROCEDURE:** Radical prostatectomy

## Key facts

- **NCT ID:** NCT05366842
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-04-01
- **Primary completion:** 2025-04-25
- **Final completion:** 2025-04-25
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** The sponsor was unable to produce and provide the study material (stravix)
- **Last updated:** 2026-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05366842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05366842, "Patient-Reported Erectile Recovery and Quality of Life Outcomes With Lyopreserved Placental Tissue Applied Directly Over Neurovascular Bundle During Nerve Sparing Radical Prostatectomy Versus Standard of Care". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05366842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*